Loading...
Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial
Peters, Niamh Morley, H Khalique, S. Scalzo, S. Patel, R. Gunaydin, U. Funingana, G. Evans, J. Papadatos-Pastos, D. Banjeri, U.
Peters, Niamh
Morley, H
Khalique, S.
Scalzo, S.
Patel, R.
Gunaydin, U.
Funingana, G.
Evans, J.
Papadatos-Pastos, D.
Banjeri, U.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Files
Keywords
Type
Meetings and Proceedings
Citation
Peters N, Morley H, Khalique S, Scalzo S, Patel R, Gunaydin U, et al. Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial. European Journal of Cancer. 2022 Oct;174:S117-S8. PubMed PMID: WOS:000876973400305.